Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

The US Commodity Futures Trading Commission (CFTC) is in “very early stages of conversations” with Facebook Inc (FB), as the regulator seeks to determine if the social media companys plans for a digital currency would fall under CFTCs scope, the Financial Times reported, citing the head of the CFTC Christopher Giancarlo.

Facebook shares closed lower for a second consecutive trading session on NASDAQ on Monday. It has also been the steepest daily loss since July 26th 2018. The stock went down 7.51% ($13.32) to $164.15, after touching an intraday low at $161.19, or a price level not seen since March 19th ($160.82).

Shares of Facebook Inc have risen 25.22% so far in 2019 compared with a 9.48% gain for the benchmark index, S&P 500 (SPX).

In 2018, Facebook Inc’s stock went down 25.71%, thus, it underperformed the S&P 500, which registered a 6.24% loss.

“We’re very interested in understanding it better,” Christopher Giancarlo said, cited by the Financial Times. “We can only act on an application, we don’t have anything in front of us,” he added.

The news followed recent reports that the social media company also discussed opportunities and regulatory issues for its crypto stablecoin (known as GlobalCoin) with government officials in the United Kingdom and the United States.

In May, Facebook Inc established Libra Networks, a financial technology company, in Geneva, Switzerland. It is owned by Ireland’s Facebook Global Holdings II, while its focus will be on developing the software and hardware for currency-related functions such as blockchain, payments, analytics, big data and identity management.

Giancarlo also said that it was too early to conclude if GlobalCoin could fall under CFTC’s scope. However, he noted that if the digital currency could be backed by the US Dollar, it would diminish the need for derivative instruments to be tied to it.

According to CNN Money, the 43 analysts, offering 12-month forecasts regarding Facebook Inc’s stock price, have a median target of $225.00, with a high estimate of $275.00 and a low estimate of $120.00. The median estimate represents a 37.07% upside compared to the closing price of $164.15 on June 3rd.

The same media also reported that 34 out of 45 surveyed investment analysts had rated Facebook Inc’s stock as “Buy”, while 6 – as “Hold”. On the other hand, 1 analyst had recommended selling the stock.

Weekly Pivot Levels

By using the traditional method of calculation, the weekly levels of importance for Facebook Inc (FB) are presented as follows:

Central Pivot Point – $179.78
R1 – $182.40
R2 – $187.33
R3 – $189.95
R4 – $192.57

S1 – $174.85
S2 – $172.23
S3 – $167.30
S4 – $162.37

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Natural Gas Remains BullishNatural Gas Remains Bullish Natural gas kept rising on Tuesday and traded 2,47% higher at $4,191 per million British units as weather forecasters predicted higher-than-average temperatures in the central parts of the U.S.When warm weather is expected, natural gas […]
  • Amazon to deploy first European Rivian vans in GermanyAmazon to deploy first European Rivian vans in Germany Key points Amazon to deploy 300 electric vans from Rivian in several areas across Germany Amazon shares close slightly lower on MondayAmazon.com Inc (AMZN) said on Tuesday that it intended to roll out its first […]
  • Forex Market: AUD/JPY trading signals for December 28thForex Market: AUD/JPY trading signals for December 28th On Monday (December 28th) AUD/JPY long positions should be opened above the hourly 55-period Exponential Moving Average (87.47) with targets set in proximity to December 22nd high of 87.80 and stops placed just below the hourly 100-period EMA […]
  • Bayer AG share price up, projects strong sales growth in pharmaceutical, healthcare and crop protection businessesBayer AG share price up, projects strong sales growth in pharmaceutical, healthcare and crop protection businesses Bayer AG made an official statement today, revealing that it expects its average annual revenue from the companys pharmaceutical business to increase by 8%, with a margin for earnings before interest, tax, amortization and depreciation of at […]
  • Natural gas futures weekly recap, June 30 – July 4Natural gas futures weekly recap, June 30 – July 4 Natural gas fell on Friday and settled the week lower as a larger-than-average build in US natural gas inventories offset weather forecasts calling for seasonal and little-above seasonal readings across most of the US in the coming weeks. […]
  • USD/SEK falls to 2-week low, next round of US tariffs loomsUSD/SEK falls to 2-week low, next round of US tariffs looms The USD/SEK currency pair hovered just above a fresh two-week low of 10.0063 on Tuesday, as market players' main focus was the upcoming reciprocal tariffs, promised by the Trump administration on April 2nd.Although US President Trump said […]